Newly launched CPhT-Adv credential supports the expanded roles of the most valuable players on the pharmacy team Read More »
Researchers recently dove into the complex answer behind the question of whether or not the United States or China holds more influence in the Indo-Pacific Region, according to a research brief from the RAND Corporation. Read More »
Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) today announced that Amit D. Munshi, the Company's President and Chief Executive Officer, is scheduled to participate in a virtual fireside chat at the 3rd Annual Evercore ISI HealthCONx Conference on Tuesday, December 1, at 4:20 PM ET. Read More »
Arcadia Consumer Healthcare is changing the way consumers improve the appearance of fungus-damaged nails with its new Opti-Nail® Fungal Nail Repair pen. Read More »
The majority receiving COVID-19 experimental treatments are those patients hospitalized with the coronavirus, Cedars-Sinai Hospital Epidemiology Director Jonathan Grein said in a recent news release. Read More »
Aridis Pharmaceuticals, Inc. (Nasdaq: ARDS), a biopharmaceutical company focused on the discovery and development of novel anti-infective therapies to treat life-threatening bacterial infections, announced that Vu Truong, Ph.D., Chief Executive Officer, will participate in Cantor Fitzgerald's Virtual Symposium: "Winning Ways to Treat Infections and COVID-19" being held on Tuesday, June 30, 2020. Read More »
Kaiser Permanente to join as a governing member with the goal of helping to secure supplies of essential generic medications during COVID-19 and beyond Read More »
Nature Made® is once again the leading choice of pharmacists in nine key vitamin and supplement segments, according to a broad survey and ranking of top recommended health products released by U.S. News & World Report, in collaboration with Pharmacy Times. Nature Made is ranked as the #1 Pharmacist Recommended brand for:1 Read More »
Under revised terms, AcelRx to acquire Tetraphase for $37.0 million in stock and cash plus CVRs Read More »
Expands Access to Testing During COVID-19 Read More »
The Synthetic Biology Leader Steps Out to Help Fight COVID-19 Read More »
AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), (AcelRx), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for use in healthcare institutions, today announced an agreement with Brigham and Women's Hospital for an investigator-initiated study led by Richard D. Urman MD, MBA, Associate Professor of Anesthesia and co-director of the Center for Perioperative Research at Brigham and Women's Hospital and Harvard Medical School. Read More »
In an effort to advocate for the communities and members they serve, Inland Empire Health Plan (IEHP) CEO, Jarrod McNaughton, contributed to the California Pharmacy Carve Out discussion in the MJH Life Sciences publication, Managed Healthcare Executive to explain how it impacts IEHP members, providers and local community. Read More »
Collaboration combines strengths to develop and commercialize life-saving antifungal treatment and prophylaxis, an area of high unmet medical need Read More »
Study Evaluated Efficacy and Safety of ABP 798 Compared to Rituxan in Patients With Non-Hodgkin's Lymphoma Read More »
More likely to seek expanded responsibilities Read More »
.jpg){kind=tracking}
The Pharmacy Technician Certification Board (PTCB) has awarded grants to four state pharmacy associations in Connecticut, Iowa, North Dakota, and Tennessee to support projects that promote medication safety and advance the role of pharmacy technicians. Read More »
First and only once-daily, nebulized bronchodilator has potential to address unmet needs of China's nearly 100 million chronic obstructive pulmonary disease (COPD) patients Read More »
Titan Pharmaceuticals, Inc. (NASDAQ: TTNP) announced that it has executed a pharmacy services agreement with Southside Specialty Pharmacy, further expanding access to treatment with Probuphine (buprenorphine) implant, Titan's novel maintenance treatment for Opioid Use Disorder (OUD) in eligible patients. Read More »
Armata Pharmaceuticals, Inc. (NYSE American: ARMP), a clinical-stage biotechnology company focused on precisely targeted bacteriophage therapeutics for antibiotic-resistant infections, announced the publication of a case study involving a cystic fibrosis patient who was successfully treated for a multidrug-resistant Pseudomonas aeruginosa infection with the Company's natural phage product, AP-PA01. Read More »
Alerts Sign-up